Market Research Report
Europe Cannabis Testing Market Forecast 2019-2027
|Published by||Inkwood Research||Product code||556991|
|Published||Content info||110 Pages
Delivery time: 2-3 business days
|Europe Cannabis Testing Market Forecast 2019-2027|
|Published: May 13, 2019||Content info: 110 Pages||
Legalization of cannabis for medical purposes has given a huge boost to the cannabis testing market. By the end of the forecast period of 2019-2027, the Europe cannabis testing market is predicted to exhibit a CAGR of 11.03%.
Although the market looks promising, a lack of uniform industry standards and high costs related to laboratory analytical instruments used for cannabis testing are presenting major challenges to the market growth. The UK market presently dominates this region. Other geographies profiled in this report include Germany, France, Italy, Spain and the Rest of Europe.
Some of the prominent market players include Digipath, Inc., Cannabilab, Restek Corporation, AB Sciex LLC, SC Laboratories, Inc., Eli Lilly, Agilent Technologies, Inc., Pharmalab, Waters Corporation, PerkinElmer, Inc., Thermo Fisher Scientific, Inc., Steep Hill Halent Laboratories, Inc., LabLynx, Inc., SDpharma Labs LLC (PharmLabs™ LLC), Accelerated Technology Laboratories, Inc., GenTech Scientific, Urofins Proxy Laboratories, Anresco Laboratories, CannaSafe Analytics, Shimadzu Corporation, Sigma-Aldrich (Acquired By Merck Group), and Test Lab Amsterdam.